tbuckley/cabot-search huggingface dataset:
Art and Anatomy
Authors: Heidi Lenssen, Lancaster M. Greene
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
INTRAVENOUS STREPTOCOCCIC VACCINE TREATMENT OF CHRONIC RHEUMATOID DISEASE
Authors: Macnider Wetherby
Journal: Annals of Internal Medicine (1941)

Article1 April 1941INTRAVENOUS STREPTOCOCCIC VACCINE TREATMENT OF CHRONIC RHEUMATOID DISEASEMACNIDER WETHERBY, M.D.MACNIDER WETHERBY, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-14-10-1849 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptStreptococcic vaccine and streptococcic derivatives have been used in the treatment of arthritis and rheumatoid diseases for a number of years. The materials injected have varied widely as to the strain or strains used, dosage, frequency, and route of administration.For the past nine years intravenous streptococcic vaccine has been used by us in the treatment of patients with chronic arthritis and associated rheumatoid complaints. These were seen at the out-patient department of the University of Minnesota hospital. The chief basis for use has been the probability that streptococci may be etiological factors in many cases of chronic arthritis and...Bibliography1. CLAWSONWETHERBY BJM a. : An experimental basis for intravenous vaccine therapy in chronic arthritis with a summary of results obtained in patients, ANN. INT. MED., 1932, v, 1147. b. WETHERBY, MACNIDER, and CLAWSON, B. J.: Intravenous streptococcic vaccine therapy in chronic arthritis, Jr. Am. Med. Assoc., 1932, xcviii, 974. Google Scholar2. REIMANNEKLUND HAC: Long-continued vaccine therapy as a cause of amyloidosis, Am. Jr. Med. Sci., 1935, cxc, 88. CrossrefGoogle Scholar3. SABINWARREN ASJ: Therapeutic effectiveness of a practically non-toxic new compound, Science, 1940, xcii, 535. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Minneapolis, Minnesota*Received for publication September 25, 1939.From the Department of Medicine, University of Minnesota. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byResistance in Rheumatism 1 April 1941Volume 14, Issue 10Page: 1849-1857KeywordsArthritisOutpatientsPatientsRheumatoid arthritisRoutes of administrationVaccines ePublished: 1 December 2008 Issue Published: 1 April 1941 PDF downloadLoading ...
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes : dose adjustment for normal eating (DAFNE) randomised controlled trial
Authors: Stephanie Amiel, Sue Beveridge, Clare Bradley, Carla Gianfrancesco, Simon Heller, Peter James, Natalie McKeown, Douglas Newton, Lynn Newton, Lindsay Oliver, Helen Reid, Sue Roberts, Susan Robson, Jackie Rollingson, Val Scott, Jane Speight, Carolin Taylor, Gillian Thompson, Eileen Turner, Frances Wright
Journal: BMJ (2002)

Objectives:  To evaluate whether a course teaching flexible intensive insulin treatment combining dietary freedom and insulin adjustment can improve both glycaemic control and quality of life in type 1 diabetes.   Design:  Randomised design with participants either attending training immediately (immediate DAFNE) or acting as waiting list controls and attending “delayed DAFNE” training 6 months later. Setting: Secondary care diabetes clinics in three English health districts.   Participants:  169 adults with type 1 diabetes and moderate or poor glycaemic control.   Main outcome measures:  Glycated haemoglobin (HbA1c), severe hypoglycaemia, impact of diabetes on quality of life (ADDQoL).   Results:  At 6 months, HbA1c was significantly better in immediate DAFNE patients (mean 8.4%) than in delayed DAFNE patients (9.4%) (t=6.1, P   Conclusion:  Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening severe hypoglycaemia or cardiovascular risk. This approach has the potential to enable more people to adopt intensive insulin treatment and is worthy of further investigation.
Suicide and Social Processes
Authors: Eric D. Caine
Journal: JAMA Psychiatry (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
SOME CLINICAL CAPRICES OF MULTIPLE MYELOMA: 15 CASE REPORTS FROM A STUDY OF 75 CASES
Authors: S O SCHWARTZ, M CATALDO
Journal: Annals of Internal Medicine (1953)

Article1 December 1953SOME CLINICAL CAPRICES OF MULTIPLE MYELOMA: 15 CASE REPORTS FROM A STUDY OF 75 CASESSTEVEN O. SCHWARTZ, M.D., F.A.C.P., MARNE CATALDO, M.D.STEVEN O. SCHWARTZ, M.D., F.A.C.P.Search for more papers by this author, MARNE CATALDO, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-39-6-1267 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptBoth the title and the general scheme of this presentation, although inevitably modified, are acknowledged to be in deliberate emulation of the superb article by William S. Middleton1 published in 1937 on the subject of Hodgkin's disease. They, the title and the scheme, and the attitude as well, are as felicitous in their application to multiple myeloma as they were to Middleton's original use in relation to Hodgkin's disease.Although the disease has been adequately described2for over a century, resistance to treatment has engendered, directly, therapeutic pessimism, and, indirectly, a lack of interest and mistaken diagnoses. The diagnosis of...Bibliography1. Middleton WS: Some clinical caprices of Hodgkin's disease, Ann. Int. Med. 11: 448-468 (Sept.) 1937. LinkGoogle Scholar2. MacIntyre W: Case of mollities and fragilitas ossium, Med-chir. Tr. London 33: 211, 1850. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication May 18, 1953.From the Hematology Laboratory and the Hektoen Institute for Medical Research of the Cook County Hospital, Chicago, Illinois.Aided by grants from the Olivia Sue Dvore and Edward Friedman Foundations. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byREFERENCESThe incidence of multiple myeloma 1 December 1953Volume 39, Issue 6Page: 1267-1280KeywordsHematology and oncologyHodgkin lymphomaMultiple myelomaResearch laboratories Issue Published: 1 December 1953 PDF downloadLoading ...
Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma
Authors: H. Müller, P. Rehberger, C. Günther, J. Schmitt
Journal: British Journal of Dermatology (2011)

Background Systemic scleroderma (SSc) is a rare disease and knowledge about the relationship between clinical signs, disability, quality of life and depressive symptoms is still limited. Although patients with SSc are frequently treated by dermatologists, the vast majority of published evidence is based on rheumatological samples. Objectives To identify determinants of disability, decreased quality of life, and depression in a sample of dermatological patients with SSc. Methods This was a cross-sectional study on consecutive patients with SSc attending one specialist dermatological centre between April 2008 and November 2009. Validated questionnaires, the Health Assessment Questionnaire (HAQ), EuroQol (EQ-5D) and the Center for Epidemiologic Studies Depression scale (CES-D) were utilized to measure disability, quality of life and depressive symptoms. Additionally, disease characteristics (SSc subtype, skin thickness, organ involvement), subjective symptoms of SSc, treatment and socioeconomic characteristics were collected by trained investigators. Based on an a priori hypothesized causal model, multivariate logistic regression models were used to analyse determinants of disability, quality of life and depression in patients with SSc. Results A total of 72 patients [59 female (82%), mean age 59 years] were enrolled. According to the CES-D, 69% (48 out of 70) were screened positive for depression. Quality of life impairment and female sex and were independent risk factors for depressive symptoms. Disease-specific disability was the main determinant of quality of life impairment in SSc. Pain involvement of the musculoskeletal system and male sex were the main determinants of disability in our sample of patients with SSc. Conclusions The high psychosomatic morbidity in our sample of consecutive patients with SSc calls for the investigation of interdisciplinary models of care.
Abstract MP49: Sugar Sweetened and Artificially Sweetened Beverages and risk of Mortality in US adults
Authors: Vasanti S Malik, An Pan, Lawrence de Koning, Eva Schernhammer, Walter C Willett, Frank B Hu
Journal: Circulation (2014)

Background: Sugar sweetened beverages (SSBs) are the single largest source of calories and added sugars in the US diet and regular consumption has been associated with weight gain and risk of chronic diseases. Artificially sweetened beverages (ASBs) are often suggested as alternatives to SSB but little is known about their long-term health effects. Whether consumption of SSBs or ASBs is associated with risk of mortality is unknown. Methods: We prospectively followed 38,602 men from the Health Professional’s Follow-up study (1986-2010) and 82,592 women from the Nurses’ Health study (1980-2010) who were free from cardiovascular disease (CVD) and cancer at baseline. Diet was assessed using validated food frequency questionnaires every 4 years and Cox Proportional Hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI). Results: We documented 27,691 deaths (6,631 CVD and 10,447 cancer deaths) during 3.14 million person-years. After adjusting for major dietary and lifestyle risk factors, and BMI, baseline diabetes, hypertension and hypercholesterolemia, consumption of SSBs was associated with an increased risk of total mortality, which was mainly driven by CVD mortality among individuals consuming at least 2 servings per day; pooled HRs (95% CIs) across categories (&lt;1/month, 1-4/month, 2-6/week, 1-&lt;2/day and ≥2/day) were 1.00, 0.95 (0.91, 0.98), 0.96 (0.93, 0.99), 1.02 (0.96, 1.08), and 1.18 (1.04, 1.33), respectively (P-trend= 0.0001) for total mortality, and 1.00, 0.97 (0.90, 1.02), 0.96 (0.90, 1.02), 1.04 (0.93, 1.16) and 1.28 (1.09, 1.51), respectively (P-trend=0.007) for CVD mortality. In contrast, ASBs were not associated with mortality; pooled HR’s (95% CIs) across categories (&lt;1/month, 1-4/month, 2-6/week, 1-&lt;2/day and ≥2/day) were 1.00, 0.92 (0.89, 0.95), 0.91 (0.86, 0.97), 0.91 (0.86, 0.95) and 0.99 (0.85, 1.15), respectively (P-trend=0.50) for total mortality and 1.00, 0.86 (0.80, 0.92), 0.87 (0.81, 0.94), 0.96 (0.88, 1.06) and 0.96 (0.74, 1.25), respectively (P-trend=0.99) for CVD mortality. No associations were observed with cancer mortality for either SSBs or ASBs in multi-variable adjusted models. Conclusion: Regular consumption of SSBs is associated with an increased risk of total and CVD mortality, providing additional support for recommendations and policies to limit intake of these beverages.
Intracellular Localization of Polyoma Virus Antigen Demonstrated With Fluoresce in Labeled Antiserums
Authors: Richard A. Malmgren, Giancarlo Rabotti, Alan S. Rabson
Journal: JNCI Journal of the National Cancer Institute (1960)

Journal Article Intracellular Localization of Polyoma Virus Antigen Demonstrated With Fluoresce in Labeled Antiserums Get access Richard A. Malmgren, Richard A. Malmgren Search for other works by this author on: Oxford Academic PubMed Google Scholar Giancarlo Rabotti, Giancarlo Rabotti Search for other works by this author on: Oxford Academic PubMed Google Scholar Alan S. Rabson Alan S. Rabson Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 24, Issue 3, March 1960, Pages 581–587, https://doi.org/10.1093/jnci/24.3.581 Published: 01 March 1960 Article history Received: 16 July 1959 Published: 01 March 1960
A Short History of Nursing from the Earliest Times to the Present Day.
Authors: Lavinia L. Dock, Isabel Maitland Stewart
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Low Triiodothyronine and Cardiovascular Disease
Authors: Giovanni Tripepi, Carmine Zoccali
Journal: Circulation (2003)

Low Triiodothyronine and Cardiovascular DiseaseTo the Editor:Iervasi et al 1 report a strong correlation between low free biologically active triiodothyronine (fT3), a thyroid hormone, and all-cause and cardiovascular mortality in 573 consecutive patients with heart disease.The observations in this study are stimulating and may be of major clinical interest.However, the following points deserve to be clarified for better appreciating the implications of this study.(1) Neither creatinine nor other markers of renal function were considered as potential confounders of the relationship between fT3 and the outcomes.This is an important omission because fT3 is frequently reduced in patients with renal failure. 2 Because it is likely that some patients with heart disease included in the Iervasi et al 1 study had some degree of renal insufficiency, fT3 may be just a proxy of renal dysfunction.(2) Cox survival analysis and logistic regression analysis do not seem to provide coherent results.In fact, the fT3 hazard ratio of 3.582 (see Cox regression model in Table 3 of Iervasi et al 1 ) implies that an increase of 1 pmol/L in fT3 is associated with a 258% excess risk for all-cause mortality.In contrast, in the multivariate logistic regression analysis (Table 4 1 ), the authors report a fT3 hazard ratio of 0.395, implying that an increase of 1 pmol/L in fT3 is associated with a 60.5% risk reduction in the hazard ratio of all-cause mortality.Finally, with just 19 cardiac deaths during the follow-up, only 2 covariates can be entered into the Cox model (ie, 1 covariate every 10 events), 3 whereas data reported in Table 3 1 apparently include 4 covariates.This model is overfitted, and, therefore, the independence of the fT3-cardiovascular outcomes link requires confirmation in a more powerful study, or requires testing in more parsimonious statistical models.
Lecture Notes on Occupational Medicine
Authors: Harry Arthur Waldron
Journal: Annals of Internal Medicine (1991)

Contents: The effects of occupation on health Industrial toxicology 1: metals Industrial toxicology 2: organic solvents Industrial toxicology 3: miscellaneous organic compounds Industrial toxicology 4: gases Occupational lung diseases Diseases of the skin Occupational cancer Physical hazards Infectious diseases Accidents and trauma Control of occupational hazards The effects of work on health Occupational health services.
Racial Disparities in Care of Heart Failure—Reply
Authors: Saif S. Rathore, Harlan M. Krumholz, Frederick A. Masoudi, Edward P. Havranek
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 10043: Arteriolar Function in Visceral Adipose Tissue is Impaired in Human Obesity
Authors: Melissa G Farb, Lisa Ganley-Leal, Melanie Mott, YanMei Liang, Michael Widlansky, Sherman J Bigornia, Antonino J Fiscale, Caroline M Apovian, Brian Carmine, Donald T Hess, Joseph A Vita, Noyan Gokce
Journal: Circulation (2011)

Melissa G Farb, 2011 Finalist and Presenting Author
An important lesson: The hazards of self management
Authors: J. Baker
Journal: BMJ (1998)

It started with a cough, just a bit of a cold. Soon I was bringing up thick green looking sputum. The sort of stuff that patients normally delight in showing you. The cough worsened and took on that rattling, bronchitic quality.

At the time I was working as a senior house officer in Australia. I had not registered with a local doctor. I had not seen the need; after all I was working in the …
Endoscopy of Larynx and Trachea with Rigid Laryngo- Tracheoscopes Under Superimposed High-Frequency Jet Ventilation (SHFJV)
Authors: Alexander Aloy, Matthaeus Grasl
Journal: Endoscopy (2013)

This chapter deals with the history of laryngoscopy and the fruitful scientific and clinical collaboration of anaesthesiologists and laryngologists in development and application of jet ventilation for surgical laryngotracheal interventions via a rigid laryngoscope.
Principles of Dermatology.
Authors: Donald P. Lookingbill, James G. Marks
Journal: Annals of Internal Medicine (1986)

Written for medical students as well as for primary care physicians, this book presents a logical approach to the diagnosis of common cutaneous diseases. Emphasis is placed on the recognition of primary skin lesions seen in the context of their clinicopathologic correlations. Each skin disorder is illustrated with a colour photograph and a graphic representation of the pathology. Therapeutic approaches are detailed as well.
Acute Gastroenteritis Hospitalizations Among US Children Following Implementation of the Rotavirus Vaccine
Authors: Eyal Leshem, Jacqueline E. Tate, Claudia A. Steiner, Aaron T. Curns, Ben A. Lopman, Umesh D. Parashar
Journal: JAMA (2015)

This retrospective observational study found that following implementation of rotavirus vaccination in 2006, all-cause acute gastroenteritis hospitalization rates among US children younger than 5 years declined by in each of the postvaccine years from 2008-2012.
Smallpox Vaccine Program Launched Amid Concerns Raised by Expert Panel, Unions
Authors: Joan Stephenson
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal